We are a frontier-biotech (deeptech) company specialised on the discovery and test of therapeutic targets and carriers for Central Nervous System unmet conditions trough our core platform. We follow a Systems biology approach, combining AI and exclusive data issued from the latest advances on animal-free experimental technologies, exclusive models based on in vitro vascularised assembloids and biohybrid computing.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Avenue Du Maine, Paris,île-De-France 75014,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://owl-lifesciences.com
- Keywords
- Central Nervous System, Advanced Therapeutic Modalities, AI - Large Biological Model, Therapies Delivery Methods, CNS Advanced In Vitro Models, Blood Brain Barrier Models, Assembloid Models Discovery Platform Approach, Biohybrid Computing Discovery Platform Approach.
- HQ
- Paris, Île-de-France
Owl Lifesciences Questions
Owl Lifesciences's website is http://owl-lifesciences.com
Owl Lifesciences's LinkedIn profile is https://fr.linkedin.com/company/owl-lifesciences
Owl Lifesciences has
2 employees.
View email and phone details for 2
employees at Owl Lifesciences.
Owl Lifesciences's industry is
Biotechnology Research
Owl Lifesciences's top competitors are
Quidditas,
Synhelix (Now Quantoom Biosciences, A Univercells Company),
Emyosound,
Ispiron Biotechnologies,
Papilio.bio,
Evariste,
Neoventures Biotechnology Europe,
Sydra,
Mb3 Biostatistics,
Cherry Biotech.
Owl Lifesciences's categories are Biotechnology Research
Owl Lifesciences's founding year is 2024
